Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Go back to Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 86.62 -0.85 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.47 | 52 Week High | $96.38 | |||
| Open | $87.38 | 52 Week Low | $47.92 | |||
| Day High | $87.64 | P/E | N/A | |||
| Day Low | $86.36 | EPS | $-0.42 | |||
| Volume | 1,891,023 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1183.46 +1.57 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1181.89 | 52 Week High | $88.16 | |||
| Open | $1185.32 | 52 Week Low | $67.88 | |||
| Day High | $1190.00 | P/E | 273.95 | |||
| Day Low | $1160.84 | EPS | $4.32 | |||
| Volume | 1,924,379 | |||||

